0.0001
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Breakdown
TTM
Operating Cash Flow
-23,881.2760
Investing Cash Flow
13,778.5050
End Cash Position
5,806.9800
Free Cash Flow
-23,881.9420
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
99B0.SG QuiaPEG Pharmaceuticals Holding AB
0.0001
0.00%
ACTI.ST Active Biotech AB (publ)
0.1060
-1.12%
BINV.ST BioInvent International AB (publ)
27.05
0.00%
CANTA.ST Cantargia AB (publ)
1.8490
+1.32%
ENDV Endonovo Therapeutics, Inc.
0.0003
+50.00%
ADXN Addex Therapeutics Ltd
7.31
-6.16%
PVCT Provectus Biopharmaceuticals, Inc.
0.1100
-0.45%
FLUO.ST FluoGuide A/S
49.55
+1.75%
CASI CASI Pharmaceuticals, Inc.
2.4950
+2.67%
ATORX.ST Alligator Bioscience AB (publ)
0.0325
-12.16%